Our work on developing human epigenome editing technologies from the most prevalent class of CRISPR-Cas systems found in nature. Type I CRISPR-Cas systems have now been harnessed for targeted eukaryotic gene regulation! #CRISPR#Cascade#TypeIsystems#CRISPRtechnologies
Cures are so rare in medicine. A dream for both types of Hemophilia to be cured with a single injection, and it's happening now https://t.co/1QtvszVSgL gene Rx @NatureMedicine
nicely summarized by @AdrianPickar and @cgersbach